Incyte Investigative Site
Winston-Salem, North Carolina 27157
We've found
1 trials
at this facility
Graft-versus-host Disease (GVHD) Clinical Trial
Updated: 12/31/1969
A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials